These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

322 related items for PubMed ID: 35183226

  • 1. A reciprocal feedback between N6-methyladenosine reader YTHDF3 and lncRNA DICER1-AS1 promotes glycolysis of pancreatic cancer through inhibiting maturation of miR-5586-5p.
    Hu Y, Tang J, Xu F, Chen J, Zeng Z, Han S, Wang F, Wang D, Huang M, Zhao Y, Huang Y, Zhuo W, Zhao G.
    J Exp Clin Cancer Res; 2022 Feb 19; 41(1):69. PubMed ID: 35183226
    [Abstract] [Full Text] [Related]

  • 2. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
    Song S, Yu W, Lin S, Zhang M, Wang T, Guo S, Wang H.
    Cancer Biol Ther; 2018 Jul 03; 19(7):573-583. PubMed ID: 29667486
    [Abstract] [Full Text] [Related]

  • 3. LncRNA DICER1-AS1 promotes the proliferation, invasion and autophagy of osteosarcoma cells via miR-30b/ATG5.
    Gu Z, Hou Z, Zheng L, Wang X, Wu L, Zhang C.
    Biomed Pharmacother; 2018 Aug 03; 104():110-118. PubMed ID: 29772430
    [Abstract] [Full Text] [Related]

  • 4. Knockdown of LncRNA DICER1-AS1 arrests the cell cycle, inhibits cell proliferation, and induces cell apoptosis by regulating CDC5L nuclear transfer in osteosarcoma.
    Fu L, Xu S, Zhou Y, Huang J, Qiu J, Huang P.
    Connect Tissue Res; 2023 Nov 03; 64(6):519-531. PubMed ID: 37310074
    [Abstract] [Full Text] [Related]

  • 5. Long non-coding RNA KTN1-AS1 promotes progression in pancreatic cancer through regulating microRNA-23b-3p/high-mobility group box 2 axis.
    Zhang ZB, Liu N.
    Aging (Albany NY); 2021 Aug 30; 13(16):20820-20835. PubMed ID: 34461605
    [Abstract] [Full Text] [Related]

  • 6. DNAH17-AS1 promotes pancreatic carcinoma by increasing PPME1 expression via inhibition of miR-432-5p.
    Xu T, Lei T, Li SQ, Mai EH, Ding FH, Niu B.
    World J Gastroenterol; 2020 Apr 21; 26(15):1745-1757. PubMed ID: 32351291
    [Abstract] [Full Text] [Related]

  • 7. M6A-mediated up-regulation of LncRNA LIFR-AS1 enhances the progression of pancreatic cancer via miRNA-150-5p/ VEGFA/Akt signaling.
    Chen JQ, Tao YP, Hong YG, Li HF, Huang ZP, Xu XF, Zheng H, Hu LK.
    Cell Cycle; 2021 Dec 21; 20(23):2507-2518. PubMed ID: 34658294
    [Abstract] [Full Text] [Related]

  • 8. A reciprocal feedback of Myc and lncRNA MTSS1-AS contributes to extracellular acidity-promoted metastasis of pancreatic cancer.
    Hu Y, Wang F, Xu F, Fang K, Fang Z, Shuai X, Cai K, Chen J, Hu P, Chen D, Xu P, Hu C, Zeng Z, Zhong J, Li W, Tang J, Huang M, Zhao Y, Wang C, Zhao G.
    Theranostics; 2020 Dec 21; 10(22):10120-10140. PubMed ID: 32929338
    [Abstract] [Full Text] [Related]

  • 9. Down-regulated lncRNA SBF2-AS1 in M2 macrophage-derived exosomes elevates miR-122-5p to restrict XIAP, thereby limiting pancreatic cancer development.
    Yin Z, Zhou Y, Ma T, Chen S, Shi N, Zou Y, Hou B, Zhang C.
    J Cell Mol Med; 2020 May 21; 24(9):5028-5038. PubMed ID: 32301277
    [Abstract] [Full Text] [Related]

  • 10. The long coding RNA AFAP1-AS1 promotes tumor cell growth and invasion in pancreatic cancer through upregulating the IGF1R oncogene via sequestration of miR-133a.
    Chen B, Li Q, Zhou Y, Wang X, Zhang Q, Wang Y, Zhuang H, Jiang X, Xiong W.
    Cell Cycle; 2018 May 21; 17(16):1949-1966. PubMed ID: 30300116
    [Abstract] [Full Text] [Related]

  • 11. CERS6-AS1 promotes cell proliferation and represses cell apoptosis in pancreatic cancer via miR-195-5p/WIPI2 axis.
    Gao KF, Zhao YF, Liao WJ, Xu GL, Zhang JD.
    Kaohsiung J Med Sci; 2022 Jun 21; 38(6):542-553. PubMed ID: 35199935
    [Abstract] [Full Text] [Related]

  • 12. LncRNA HIF1A-AS1 Promotes Gemcitabine Resistance of Pancreatic Cancer by Enhancing Glycolysis through Modulating the AKT/YB1/HIF1α Pathway.
    Xu F, Huang M, Chen Q, Niu Y, Hu Y, Hu P, Chen D, He C, Huang K, Zeng Z, Tang J, Wang F, Zhao Y, Wang C, Zhao G.
    Cancer Res; 2021 Nov 15; 81(22):5678-5691. PubMed ID: 34593522
    [Abstract] [Full Text] [Related]

  • 13. The m6A modification-mediated positive feedback between glycolytic lncRNA SLC2A1-DT and c-Myc promotes tumorigenesis of hepatocellular carcinoma.
    Zeng Z, Wang J, Xu F, Hu P, Hu Y, Zhuo W, Chen D, Han S, Wang F, Zhao Y, Huang Y, Zhao G.
    Int J Biol Sci; 2024 Nov 15; 20(5):1744-1762. PubMed ID: 38481809
    [Abstract] [Full Text] [Related]

  • 14. DICER1-AS1 Promotes the Malignant Behaviors of Colorectal Cancer Cells by Regulating miR-296-5p/STAT3 Axis.
    Ma C, Ma N, Qin L, Miao C, Luo M, Liu S.
    Cancer Manag Res; 2020 Nov 15; 12():10035-10046. PubMed ID: 33116860
    [Abstract] [Full Text] [Related]

  • 15. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
    Wang Y, Yang L, Chen T, Liu X, Guo Y, Zhu Q, Tong X, Yang W, Xu Q, Huang D, Tu K.
    Mol Cancer; 2019 Feb 19; 18(1):28. PubMed ID: 30782188
    [Abstract] [Full Text] [Related]

  • 16. Long non-coding RNA PXN-AS1 suppresses pancreatic cancer progression by acting as a competing endogenous RNA of miR-3064 to upregulate PIP4K2B expression.
    Yan J, Jia Y, Chen H, Chen W, Zhou X.
    J Exp Clin Cancer Res; 2019 Sep 05; 38(1):390. PubMed ID: 31488171
    [Abstract] [Full Text] [Related]

  • 17. Long noncoding RNA GAS5 inhibits progression of colorectal cancer by interacting with and triggering YAP phosphorylation and degradation and is negatively regulated by the m6A reader YTHDF3.
    Ni W, Yao S, Zhou Y, Liu Y, Huang P, Zhou A, Liu J, Che L, Li J.
    Mol Cancer; 2019 Oct 16; 18(1):143. PubMed ID: 31619268
    [Abstract] [Full Text] [Related]

  • 18. Long noncoding RNA SLC2A1-AS1 regulates aerobic glycolysis and progression in hepatocellular carcinoma via inhibiting the STAT3/FOXM1/GLUT1 pathway.
    Shang R, Wang M, Dai B, Du J, Wang J, Liu Z, Qu S, Yang X, Liu J, Xia C, Wang L, Wang D, Li Y.
    Mol Oncol; 2020 Jun 16; 14(6):1381-1396. PubMed ID: 32174012
    [Abstract] [Full Text] [Related]

  • 19. Chidamide inhibits cell glycolysis in acute myeloid leukemia by decreasing N6-methyladenosine-related GNAS-AS1.
    Hu C, Fu X, Li S, Chen C, Zhao X, Peng J.
    Daru; 2024 Jun 16; 32(1):11-24. PubMed ID: 37926762
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.